This study aims to observe the antifibrotic effect of peroxisome proliferator-activated receptor-γ (PPARγ) agonist on corneal fibroblasts cultured in vitro, and to explore the potential application of peroxisome proliferator-activated receptor agonist to the prevention of corneal opacity following wound repair. The gene discussed is PPARG; the disease is Corneal opacity.